Thermo Fisher Scientific
As new ways of delivering healthy genetic material to target cells are found, the potential to treat and prevent genetic diseases is extraordinary. Connect to our resource library to accelerate your gene therapy knowledge.
In this webinar, speakers Scott Cross from Dark Horse Consulting Group, and Thermo Fisher's Shikha Mishra share their thoughts on regulatory compliance throughout the therapeutic development lifecycle and advise on best practices for producing high-quality viral vectors at scale.
Discover how to meet rapidly growing demand for AAV vector from both technology development and manufacturing strategy viewpoints, and more.
Tune into this webinar and learn all about the drivers and challenges of decentralized manufacturing from industry leaders.
Watch this webinar and explore upstream and downstream solutions across the AAV production workflows.
This webinar features REGENXBIO and viral clearance data using Thermo Fisher Scientific’s POROS CaptureSelect AAVX affinity resin, as well as an overview on AAV production.
Panelists from Thermo Fisher Scientific, Catapult, Affinia, SioGene, and Ultragenyx discuss process intensification with a wide variety of topics regarding vector manufacturing.
Download our infographic to learn about how analytical solutions such as accurate measurement, mass confirmation, and characterization can help accelerate your AAV gene therapy.
Download this infographic and explore a suite of scalable and robust solutions for all stages of the gene therapy workflow, from development through to commercialization.
Download our infographic to learn about the development of gene therapies, successes & challenges in gene therapy research, and things to consider through each stage of the workflow.
The advancement of viral-vector gene therapies has enabled the industry to evolve and refine manufacturing scale-up approaches to generate viral vectors for a multitude of applications and target cells.
This eBook delves into accelerating gene therapy developments, manufacturing solutions, and the outcomes, successes, and possible pitfalls in gene therapy research.
Discover why the quality of raw materials needs to be considered according to the stage of development of the cell or gene therapy.
In this ‘Ask the experts’ feature, a panel of key thought leaders share their perspectives on current obstacles and future developments in scale-up and process development.
Producing safe, effective, and reproducible gene therapies can be more complicated than meets the eye. We will work with you as your reliable, full-service partner at every phase.
Find out how Thermo Fisher Scientific can connect you to cell and gene therapy products, services and solutions to help you progress.
Download our case study to learn how the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University created efficiencies in cell and gene therapy manufacturing by collaborating with Thermo Fisher Scientific as a single partner.
Discover how to reduce impurities while maintaining the highest yield in process development and manufacturing for viral vectors.
Discoveries in gene and cell therapies are happening every day. Learn how to achieve seamless transitions from the discovery to the production phase by using a controlled-rate freezer.
New GMP-focused laboratory solutions are easing the transition from cell and gene therapy research to GMP production.
Learn how real-time supervision of critical laboratory equipment parameters can boost laboratory efficiency and productivity by reducing sample failures.
Learn how an electronically monitored BSC can provide a strong link in the aseptic processing chain, maintaining safety and quality, and simplifying the compliance process.
Researchers face enormous pressure in maintaining their adherence to cGMP standards. Discover how Thermo Fisher Scientific focuses on simplifying cGMP compliance.
In this article, specialists from Thermo Fisher Scientific, Homology Medicines Inc, and Viralgen discuss the many challenges associated with bringing a gene therapy product to market.